Download FREE Report Sample
Download Free sampleRivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8?12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
Rivaroxaban Market contains market size and forecasts of Rivaroxaban in global, including the following market information:
Global Rivaroxaban Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rivaroxaban Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Rivaroxaban companies in 2021 (%)
The global Rivaroxaban market was valued at 8226.5 million in 2021 and is projected to reach US$ 13960 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
2.5 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rivaroxaban include Bayer and J&J etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rivaroxaban manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rivaroxaban Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Rivaroxaban Market Segment Percentages, by Type, 2021 (%)
2.5 mg
10 mg
15 mg
20 mg
Global Rivaroxaban Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Rivaroxaban Market Segment Percentages, by Application, 2021 (%)
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
Global Rivaroxaban Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Rivaroxaban Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rivaroxaban revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rivaroxaban revenues share in global market, 2021 (%)
Key companies Rivaroxaban sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Rivaroxaban sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
J&J
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
